Etiologies of acute liver failure

Seminars in Liver Disease

Volumn 28, Issue 2, 2008, Pages 142-152

  Lee, William M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Acetaminophen; Acute liver failure; Budd Chiari syndrome; Drug induced liver injury; Hepatitis; Wilson's disease

Indexed keywords

PARACETAMOL;

AFRICA; ASIA; AUTOIMMUNE DISEASE; BUDD CHIARI SYNDROME; DEVELOPING COUNTRY; DRUG OVERDOSE; EUROPE; HEPATITIS B; HEPATITIS E; HUMAN; INFECTION; ISCHEMIA; KIDNEY FAILURE; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; LUNG INSUFFICIENCY; MENTAL HEALTH; NORTH AMERICA; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REPEATED DRUG DOSE; REVIEW; TREATMENT OUTCOME; VASODILATATION; VIRUS INFECTION; WILSON DISEASE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; BUDD-CHIARI SYNDROME; DRUG THERAPY; FEMALE; HEPATITIS; HEPATOLENTICULAR DEGENERATION; HUMANS; IMMUNITY, NATURAL; LIVER FAILURE, ACUTE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 43049137743     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1073114     Document Type: Review

References (82)

1. Ritt DJ, Whelan G, Werner DJ, Eigenbrodt EH, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma: an analysis of thirty-one patients. Medicine 1969;48:151-172
2. Rakela J, Mosley JW, Edwards VM, and the Acute Hepatic Failure Study Group. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. Dig Dis Sci 1991;36:1223-1228
3. Schiødt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999;5:29-34
4. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6:163-169
5. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954
6. Escorsell A, Mas A, de la Mata M, and the Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007;13:1389-1395
7. Schiødt FV, Lee WM. Drug-induced liver injury. In: Yamada Atlas of Gastroenterology and Hepatology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2008:637-640
8. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996;23:1448-1455
9. Jilani N, Das BC, Husain SA, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007;22:676-682
10. Proceedings of the Food and Drug Administration Non-prescription Drugs Advisory Committee meeting; September 19, 2002; Silver Spring, MD. Testimony of Parivash Nourjah, Ph.D. Available at: www.fda.gov/ohrms/dockets/ac/cder02. htm#NonprescriptionDrugs. Accessed March 31, 2008
11. Larson AM, Poison J, Fontana RJ, et al, and the Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364-1372
12. http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/ 092007/407652/article.pdf. Accessed March 31, 2008
13. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007;102:2459-2463
14. Davern TJ II, James LP, Hinson JA, et al, and the Acute Liver Failure Study Group. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006;130:687-694
15. James LP, Alonso EM, Hynan LS, et al, and the Pediatric Acute Liver Failure Study Group. Detection of acetaminophen-protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006;118:e676-e681
16. Bertholf RL, Johannsen LM, Bazooband A, Mansouri V. False-positive acetaminophen results in a hyperbilirubinemic patient. Clin Chem 2003;49:695-698
17. Beuhler MC, Curry SC. False positive acetaminophen levels associated with hyperbilirubinemia. Clin Toxicol (Phila) 2005;43:167-170; erratum 325
18. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 2001;322:1203-1207
19. Sheen CL, Dillon JF, Bateman DN, et al. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and Ibuprofen. Pharmacoepidemiol Drug Saf 2002;11:329-331
20. Lee WM. Acetaminophen toxicity: changing perceptions of a social/medical issue. Hepatology 2007;46:966-970
21. Department of Health and Human Services. Food and Drug Administration 21 CFR Parts 201 and 343 [Docket No. 1977N-0094L] RIN 0910-AF36. Internal Analgesic, Antipyretic, and Anti-rheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling. Available at: http://www.accessdata.fda.gov/ scripts/oc/ohrms/frbydocket.cfm. Accessed March 31, 2008
22. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002;22:137-144
23. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-499
24. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007;25:1135-1151
25. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006;354:731-739
26. Fuchs S, Simon Z, Brezis M. Fatal hepatic failure associated with ciprofloxacin. Lancet 1994;343:738-739
27. Clay KD, Hanson JS, Pope SD, Rissmiller RW, Purdum PP III, Banks PM. Brief communication: severe hepatotoxicity of telithromycin - three case reports and literature review. Ann Intern Med 2006;144:415-420
28. Taylor RM, Davern TJ, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 2006;44:1589-1597
29. Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol 2006;5:231-236
30. Ikeda K, Shiga Y, Takahashi A, et al. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma 2006;47:155-157
31. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006;44:326-334
32. Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307
33. Tillmann HL, Hadem J, Leifeld L, et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006;13:256-263
34. Reshef R, Sbeit W, Tur-Kaspa R. Lamivudine in the treatment of acute hepatitis B. N Engl J Med 2000;343:1123-1124
35. Kumar M, Satapathy S, Monga R, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007;45:97-101
36. Seremba E, Sanders C, Jain M, et al, and the Acute Liver Failure Study Group. Use of nucleoside analogues in HBV-related acute liver failure. Hepatology 2007;46(suppl):276A
37. Teo EK, Ostapowicz GA, Hussain M, Lee WM, Fontana RJ, Lok ASF, and US Acute Liver Failure Study Group. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001;33:972-976
38. Umemura T, Tanaka E, Ostapowicz G, et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, aplastic anemia and acute and chronic non-A-E hepatitis. J Infect Dis 2003;188:1545-1552
39. Lee WM, Brown KE, Young NS, et al, and the Acute Liver Failure Study Group. Brief report: no evidence for hepatitis E or parvovirus B19 infection in patients with acute liver failure. Dig Dis Sci 2006;51:1712-1715
40. Ichai P, Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl 2005;11:1550-1555
41. Levitsky J, Thadareddy A, Lakeman FA, et al. Herpes simplex virus in acute liver failure. Gastroenterology 2007;132(suppl 2):A-752
42. Nakazawa H, Ito T, Makashima H, et al. Adenovirus fulminant hepatic failure: disseminated adenoviral disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Intern Med 2006;45:975-980
43. Ferrari R, Pappas G, Agostinelli D, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the "acute" type. OJM 2004;97:407-412
44. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004;2:625-631
45. Sharp JR, Ishak KG, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 1980;92:14-19
46. Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000;95:560-561
47. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematous-like syndrome. BMJ 1996;312:169-172
48. Misdraji J, Thiim M, Graeme-Cook FM. Autoimmune hepatitis with centrilobular necrosis. AmJ Surg Pathol 2004;28:471-478
49. Menon KVN, Shah V, Kamath P. The Budd-Chiari syndrome. N Engl J Med 2004;350:578-585
50. Kuo PC, Johnson LB, Hastings G, et al. Fulminant hepatic failure from the Budd-Chiari syndrome: a bridge to transplantation with transjugular intrahepatic portosystemic shunt. Transplantation 1996;62:294-296
51. Ryu RK, Durham JD, Krysl J, et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999;10:799-805
52. Shrestha R, Durham J, Wachs M, et al. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Am J Gastroenterol 1997;92:2304-2306
53. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 1990;11:59-64
54. Halim A, Kanayama N, El Maradny E, et al. A study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy. Gynecol Obstet Invest 1996;41:106-112
55. Lindheimer MD. Unraveling the mysteries of preeclampsia. Am J Obstet Gynecol 2005;193:3-4
56. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683
57. Bacq Y. Acute fatty liver of pregnancy. Semin Perinatol 1998;22:134-140
58. Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986;6:859-863
59. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129-1134
60. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003;37:1475-1492
61. Sallie R, Katsiyiannakis L, Baldwin D, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 1992;16:1206-1211
62. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129-1134
63. Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-218
64. Jhang JS, Schilsky ML, Lefkowitch JH, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher 2007;22:10-14
65. Asfaha S, Almansori M, Qarni U, Gutfreund KS. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease. J Clin Apher 2007;22:295-298
66. Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 1998;42:576-580
67. Agarwal K, Jones DE, Burt AD, Hudson M, James OF. Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. Am J Gastroenterol 2002;97:750-751
68. Rubio S, Barbero-Villares A, Reina T, Nieto S, Mendoza J, Garcia-Buey L. Rapidly-progressive liver failure secondary to melanoma infiltration. Gastroenterol Hepatol 2005;28:619-621
69. Bhat YM, Krasinskas A, Craig FE, Shaw-Stiffel TA. Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy. Dig Dis Sci 2006;51:63-67
70. Cameron AM, Truty J, Truell J, et al. Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy. Transplantation 2005;80:993-996
71. Garcin JM, Bronstein JA, Cremades S, Courbin P, Cointet F. Acute liver failure is frequent during heat stroke. World J Gastroenterol 2008;14:158-159
72. Hadad E, Ben-Ari Z, Heled Y, Moran DS, Shani Y, Epstein Y. Liver transplantation in exertional heat stroke: a medical dilemma. Intensive Care Med 2004;30:1474-1478
73. Broessner G, Beer R, Franz G, et al. Case report: severe heat stroke with multiple organ dysfunction - a novel intravascular treatment approach. Crit Care 2005;9:R498-R501
74. Berger J, Hart J, Millis M, Baker AL. Fulminant hepatic failure from heat stroke requiring liver transplantation. J Clin Gastroenterol 2000;30:429-431
75. Poison J, Lee WM. AASLD position paper: acute liver failure. Hepatology 2005;41:1179-1197
76. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007;47:664-670
77. Ichai P, Duclos-Vallée JC, Guettier C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007;13:996-1003
78. Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation. Liver Transpl 2007;13:953-955
79. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007;46:1650-1658
80. Ojetti V, Fini L, Zileri Dal Verme L, Migneco A, Pola P, Gasbarrini A. Acute cryptogenic liver failure in an untreated coeliac patient: a case report. Eur J Gastroenterol Hepatol 2005;17:1119-1121
81. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003;163:1566-1572
82. Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol 2004;2:107-112